Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Medulloblastoma | 4 | 2022 | 683 | 0.440 |
Why?
|
Cerebellar Neoplasms | 3 | 2022 | 587 | 0.270 |
Why?
|
Bone Marrow Examination | 1 | 2004 | 157 | 0.240 |
Why?
|
Cranial Irradiation | 3 | 2022 | 401 | 0.220 |
Why?
|
Protons | 4 | 2022 | 1127 | 0.210 |
Why?
|
Burkitt Lymphoma | 1 | 2004 | 327 | 0.210 |
Why?
|
Leukemia, Myelomonocytic, Juvenile | 1 | 2019 | 20 | 0.180 |
Why?
|
Eosinophilia | 1 | 2004 | 541 | 0.180 |
Why?
|
Pituitary Gland | 2 | 2018 | 665 | 0.160 |
Why?
|
Ependymoma | 1 | 2021 | 334 | 0.150 |
Why?
|
Bone Marrow | 2 | 2019 | 2948 | 0.140 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2022 | 806 | 0.140 |
Why?
|
Dacryocystitis | 1 | 2016 | 70 | 0.130 |
Why?
|
Neoplasms | 6 | 2023 | 21683 | 0.120 |
Why?
|
Infusion Pumps, Implantable | 1 | 2014 | 156 | 0.110 |
Why?
|
Injections, Spinal | 1 | 2014 | 303 | 0.110 |
Why?
|
Brain Neoplasms | 3 | 2022 | 8863 | 0.110 |
Why?
|
Pain, Intractable | 1 | 2014 | 130 | 0.110 |
Why?
|
Radiation Injuries | 2 | 2018 | 1180 | 0.110 |
Why?
|
Fertility | 2 | 2018 | 781 | 0.110 |
Why?
|
Hypothalamus | 1 | 2018 | 1063 | 0.110 |
Why?
|
Lymphoproliferative Disorders | 1 | 2016 | 523 | 0.110 |
Why?
|
Spinal Cord Neoplasms | 1 | 2014 | 281 | 0.100 |
Why?
|
Medical Oncology | 1 | 2023 | 2265 | 0.100 |
Why?
|
Organs at Risk | 3 | 2022 | 346 | 0.090 |
Why?
|
Translocation, Genetic | 2 | 2007 | 1420 | 0.090 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2016 | 570 | 0.090 |
Why?
|
Anemia | 1 | 2019 | 1506 | 0.090 |
Why?
|
Radiotherapy Dosage | 4 | 2022 | 2879 | 0.090 |
Why?
|
Lymphoma, Follicular | 1 | 2012 | 435 | 0.080 |
Why?
|
Urticaria Pigmentosa | 1 | 2007 | 17 | 0.080 |
Why?
|
Leukemic Infiltration | 1 | 2007 | 48 | 0.080 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 3255 | 0.070 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 1519 | 0.070 |
Why?
|
Guidelines as Topic | 1 | 2014 | 1405 | 0.070 |
Why?
|
Analgesics | 1 | 2014 | 1040 | 0.070 |
Why?
|
Gene Rearrangement | 1 | 2012 | 1179 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2012 | 1434 | 0.060 |
Why?
|
Child | 11 | 2022 | 77709 | 0.060 |
Why?
|
Adolescent | 12 | 2023 | 85781 | 0.060 |
Why?
|
Pediatrics | 1 | 2018 | 3475 | 0.060 |
Why?
|
Young Adult | 10 | 2023 | 56430 | 0.060 |
Why?
|
Lymph Nodes | 1 | 2012 | 3474 | 0.050 |
Why?
|
In Situ Hybridization | 1 | 2004 | 1950 | 0.050 |
Why?
|
Stroke | 1 | 2022 | 9981 | 0.040 |
Why?
|
Delphi Technique | 1 | 2022 | 778 | 0.040 |
Why?
|
Glioma | 1 | 2014 | 3401 | 0.040 |
Why?
|
Diagnosis, Differential | 3 | 2019 | 12959 | 0.040 |
Why?
|
Bone Neoplasms | 1 | 2011 | 2529 | 0.040 |
Why?
|
Child, Preschool | 6 | 2018 | 41006 | 0.040 |
Why?
|
Fatigue | 1 | 2004 | 1531 | 0.040 |
Why?
|
Cardiomegaly | 1 | 2019 | 620 | 0.040 |
Why?
|
Hippocampus | 2 | 2022 | 3675 | 0.040 |
Why?
|
Cell Proliferation | 1 | 2012 | 10481 | 0.040 |
Why?
|
Fatal Outcome | 2 | 2014 | 1850 | 0.030 |
Why?
|
Endocrine System Diseases | 1 | 2018 | 248 | 0.030 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2018 | 629 | 0.030 |
Why?
|
Humans | 19 | 2023 | 744343 | 0.030 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2018 | 255 | 0.030 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2021 | 1770 | 0.030 |
Why?
|
Counseling | 1 | 2023 | 1523 | 0.030 |
Why?
|
Behavior | 1 | 2018 | 561 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2016 | 6895 | 0.030 |
Why?
|
Optic Chiasm | 1 | 2014 | 87 | 0.030 |
Why?
|
Skin | 1 | 2007 | 4364 | 0.030 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2022 | 1624 | 0.030 |
Why?
|
Condylomata Acuminata | 1 | 2014 | 82 | 0.030 |
Why?
|
Vulvar Diseases | 1 | 2014 | 61 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2004 | 5974 | 0.030 |
Why?
|
Consensus | 1 | 2022 | 2959 | 0.030 |
Why?
|
Radiography, Thoracic | 1 | 2019 | 1265 | 0.030 |
Why?
|
Adolescent Medicine | 1 | 2012 | 72 | 0.030 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2007 | 3523 | 0.030 |
Why?
|
Infant | 4 | 2019 | 35136 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 2019 | 2765 | 0.020 |
Why?
|
Radiodermatitis | 1 | 2011 | 60 | 0.020 |
Why?
|
Male | 9 | 2019 | 350118 | 0.020 |
Why?
|
Radiotherapy, Conformal | 1 | 2014 | 548 | 0.020 |
Why?
|
Disease Progression | 2 | 2021 | 13284 | 0.020 |
Why?
|
Aspirin | 1 | 2022 | 3282 | 0.020 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2014 | 547 | 0.020 |
Why?
|
Palliative Care | 2 | 2018 | 3493 | 0.020 |
Why?
|
Anus Neoplasms | 1 | 2014 | 332 | 0.020 |
Why?
|
Ki-67 Antigen | 1 | 2012 | 644 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2022 | 9239 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2016 | 2971 | 0.020 |
Why?
|
Relative Biological Effectiveness | 1 | 2011 | 323 | 0.020 |
Why?
|
Prognosis | 3 | 2016 | 29063 | 0.020 |
Why?
|
Intelligence | 1 | 2014 | 920 | 0.020 |
Why?
|
Neutropenia | 1 | 2014 | 895 | 0.020 |
Why?
|
Age Factors | 2 | 2016 | 18370 | 0.020 |
Why?
|
Female | 9 | 2018 | 380194 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2016 | 3616 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2012 | 1880 | 0.020 |
Why?
|
Survival Rate | 2 | 2012 | 12788 | 0.020 |
Why?
|
Echocardiography | 1 | 2019 | 5102 | 0.020 |
Why?
|
Disease Management | 1 | 2018 | 2459 | 0.020 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2007 | 417 | 0.020 |
Why?
|
Temporal Lobe | 1 | 2014 | 1670 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2021 | 63114 | 0.020 |
Why?
|
Erythema | 1 | 2007 | 257 | 0.020 |
Why?
|
Electrocardiography | 1 | 2019 | 6442 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2012 | 2649 | 0.020 |
Why?
|
Terminal Care | 1 | 2018 | 1694 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8642 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6538 | 0.020 |
Why?
|
Parents | 1 | 2018 | 3407 | 0.020 |
Why?
|
Cohort Studies | 2 | 2021 | 40561 | 0.020 |
Why?
|
Pain Measurement | 1 | 2014 | 3420 | 0.010 |
Why?
|
Pregnancy | 2 | 2018 | 29144 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2004 | 11524 | 0.010 |
Why?
|
Neoplasms, Second Primary | 1 | 2011 | 1061 | 0.010 |
Why?
|
Retrospective Studies | 3 | 2021 | 77449 | 0.010 |
Why?
|
Survival Analysis | 1 | 2016 | 10252 | 0.010 |
Why?
|
Risk Assessment | 2 | 2016 | 23338 | 0.010 |
Why?
|
Remission Induction | 1 | 2007 | 2386 | 0.010 |
Why?
|
Sex Factors | 1 | 2016 | 10397 | 0.010 |
Why?
|
Patient Compliance | 1 | 2012 | 2684 | 0.010 |
Why?
|
Risk Factors | 2 | 2023 | 72290 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2016 | 11031 | 0.010 |
Why?
|
Lung | 1 | 2019 | 9856 | 0.010 |
Why?
|
Incidence | 1 | 2018 | 20947 | 0.010 |
Why?
|
Skin Diseases | 1 | 2007 | 1065 | 0.010 |
Why?
|
Early Detection of Cancer | 1 | 2012 | 3086 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2014 | 4034 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 53288 | 0.010 |
Why?
|
Quality of Life | 1 | 2018 | 12804 | 0.010 |
Why?
|
Cognition | 1 | 2014 | 6770 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39050 | 0.010 |
Why?
|
Aged | 2 | 2023 | 163280 | 0.010 |
Why?
|
Recurrence | 1 | 2007 | 8340 | 0.010 |
Why?
|
Adult | 3 | 2014 | 214055 | 0.010 |
Why?
|
Time Factors | 1 | 2016 | 40075 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2012 | 25625 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 35421 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2012 | 57776 | 0.000 |
Why?
|
Middle Aged | 1 | 2012 | 213383 | 0.000 |
Why?
|
Concepts
(137)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(45)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_